Increased sputum endotoxin levels are associated with an impaired lung function response to oral steroids in asthmatic patients

Journal of Allergy and Clinical Immunology

Volumn 134, Issue 5, 2014, Pages 1068-1075

  Mcsharry, Charles ^a   Spears, Mark ^a   Chaudhuri, Rekha ^a   Cameron, Euan J ^a   Husi, Holger ^a   Thomson, Neil C ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Asthma; asthma control; endotoxin; oral steroids; smokers; sputum cytokines

Indexed keywords

CORTICOSTEROID; DEXAMETHASONE; ENDOTOXIN; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 6; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; CYTOKINE;

ADULT; ARTICLE; ASTHMA; BLOOD LEVEL; CONTROLLED STUDY; CORTICOSTEROID INSENSITIVITY; CORTICOSTEROID THERAPY; DRUG SENSITIVITY; ENZYME IMMUNOASSAY; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; QUANTITATIVE ASSAY; SMOKING; SPUTUM LEVEL; TREATMENT DURATION; LUNG; LUNG FUNCTION TEST; METABOLISM; MIDDLE AGED; ORAL DRUG ADMINISTRATION; PATHOPHYSIOLOGY; SPUTUM;

ADMINISTRATION, ORAL; ADRENAL CORTEX HORMONES; ADULT; ASTHMA; CYTOKINES; ENDOTOXINS; FEMALE; HUMANS; LUNG; MALE; MIDDLE AGED; RESPIRATORY FUNCTION TESTS; SMOKING; SPUTUM;

EID: 84913573359     PISSN: 00916749     EISSN: 10976825     Source Type: Journal    
DOI: 10.1016/j.jaci.2014.08.022     Document Type: Article

References (45)

1. P.J. Barnes, and I.M. Adcock Glucocorticoid resistance in inflammatory diseases Lancet 373 2009 1905 1917
2. S.E. Wenzel Asthma phenotypes: the evolution from clinical to molecular approaches Nat Med 18 2012 716 725
3. M. Spears, E. Cameron, R. Chaudhuri, and N.C. Thomson Challenges of treating asthma in people who smoke Expert Rev Clin Immunol 6 2010 257 268
4. G.W. Chalmers, K.J. Macleod, S.A. Little, L.J. Thomson, C.P. McSharry, and N.C. Thomson Influence of cigarette smoking on inhaled corticosteroid treatment in mild asthma Thorax 57 2002 226 230
5. S.C. Lazarus, V.M. Chinchilli, N.J. Rollings, H.A. Boushey, R. Cherniack, and T.J. Craig Smoking affects response to inhaled corticosteroids or leukotriene receptor antagonists in asthma Am J Respir Crit Care Med 175 2007 783 790
6. R. Chaudhuri, E. Livingston, A.D. McMahon, L. Thomson, W. Borland, and N.C. Thomson Cigarette smoking impairs the therapeutic response to oral corticosteroids in chronic asthma Am J Respir Crit Care Med 168 2003 1308 1311
7. P.J. Barnes Corticosteroid resistance in patients with asthma and chronic obstructive pulmonary disease J Allergy Clin Immunol 131 2013 636 645
8. Z. Komlósi, E. Pozsonyi, T. Tábi, E. Szök, A. Nagy, and B. Bartos Lipopolysaccharide exposure makes allergic airway inflammation and hyper-responsiveness less responsive to dexamethasone and inhibition of iNOS Clin Exp Allergy 36 2006 951 959
9. M. Yang, R.K. Kumar, and P.S. Foster Pathogenesis of Steroid-resistant airway hyperresponsiveness: interaction between IFN-γ and TLR4/MyD88 pathways J Immunol 182 2009 5107 5115
10. N. Hirasawa, K. Yashima, and K. Ishihara Enhancement of ligand-dependent down-regulation of glucocorticoid receptor by lipopolysaccharide Life Sci 85 2009 578 585
11. E. Goleva, P.J. Hauk, C.F. Hall, A.H. Liu, D.W.H. Riches, and R.J. Martin Corticosteroid-resistant asthma is associated with classical antimicrobial activation of airway macrophages J Allergy Clin Immunol 122 2008 550 559
12. J.L. Simpson, T.V. Grissell, J. Douwes, R.J. Scott, M.J. Boyle, and P.G. Gibson Innate immune activation in neutrophilic asthma and bronchiectasis Thorax 62 2007 211 218
13. P.J. Hauk, M. Krawiec, J. Murphy, J. Boguniewicz, A. Schiltz, and E. Goleva Neutrophilic airway inflammation and association with bacterial lipopolysaccharide in children with asthma and wheezing Pediatr Pulmonol 43 2008 916 923
14. J.D. Hasday, R. Bascom, J.J. Costa, T. Fitzgerald, and W. Dubin Bacterial endotoxin is an active component of cigarette smoke Chest 115 1999 829 835
15. A. Sebastian, C. Pehrson, and L. Larsson Elevated concentrations of endotoxin in indoor air due to cigarette smoking J Environ Monit 8 2006 519 522
16. L. Larsson, B. Szponar, and C. Pehrson Tobacco smoking increases dramatically air concentrations of endotoxin Indoor Air 14 2004 421 424
17. P. Thorne, R. Cohn, D. Mav, S. Arbes, and D. Zeldin Predictors of endotoxin levels in U.S. housing Environ Health Perspect 117 2009 763 771
18. V. Doreswamy, and D.B. Peden Modulation of asthma by endotoxin Clin Exp Allergy 41 2011 9 19
19. M.K. Han, Y.J. Huang, J.J. LiPuma, H.A. Boushey, R.C. Boucher, and W.O. Cookson Significance of the microbiome in obstructive lung disease Thorax 67 2012 456 463
20. Y.J. Huang, C.E. Nelson, E.L. Brodie, T.Z. DeSantis, M.S. Baek, and J. Liu Airway microbiota and bronchial hyperresponsiveness in patients with suboptimally controlled asthma J Allergy Clin Immunol 127 2011 372 381.e3
21. 99mTc-DTPA in asthma Am Rev Respir Dis 139 1988 1139 1143
22. M. Spears, C. McSharry, R. Chaudhuri, C.J. Weir, C. de Wet, and N.C. Thomson Smoking in asthma is associated with elevated levels of corticosteroid resistant sputum cytokines - an exploratory study PLoS One 8 2013 e71460
23. M.R. Miller, J. Hankinson, V. Brusasco, F. Burgos, R. Casaburi, and A. Coates ATS/ERS Task Force Standardisation of Lung Function Testing: standardisation of spirometry Eur Respir J 26 2005 319 338
24. E.F. Juniper, P.M. O'Byrne, G.H. Guyatt, P.J. Ferrie, and D.R. King Development and validation of a questionnaire to measure asthma control Eur Respir J 14 1999 902 907
25. M. Spears, I. Donnelly, L. Jolly, M. Brannigan, K. Ito, and C. McSharry Effect of low-dose theophylline plus beclometasone on lung function in smokers with asthma: a pilot study Eur Respir J 33 2009 1010 1017
26. C. Garlanda, C. Dinarello, and A. Mantovani The interleukin-1 family: back to the future Immunity 39 2013 1003 1018
27. M.J. Beckman, J. Sotos, F. Leite, L.A. Schuler, and C.J. Czuprynski Differential gene regulation of interleukin-1 ligands and receptors in bovine peripheral blood neutrophils and mononuclear cells in response to E. coli lipopolysaccharide (LPS) Vet Immunol Immunopathol 77 2000 221 232
28. M. Hilty, C. Burke, H. Pedro, P. Cardenas, A. Bush, and C. Bossley Disordered microbial communities in asthmatic airways PLoS One 5 2010 e8578
29. P.R. Marri, D.A. Stern, A.L. Wright, D. Billheimer, and F.D. Martinez Asthma-associated differences in microbial composition of induced sputum J Allergy Clin Immunol 131 2013 346 352
30. E. Goleva, L.P. Jackson, J.K. Harris, C.E. Robertson, E.R. Sutherland, and C.F. Hall The effects of airway microbiome on corticosteroid responsiveness in asthma Am J Respir Crit Care Med 188 2013 1193 1201
31. M. Spears, and N.C. Thomson Factors influencing individual variability to the therapeutic response to corticosteroids Curr Respir Med Rev 2 2006 197 209
32. E. Irusen, J. Matthews, A. Takahashi, P. Barnes, K. Chung, and I. Adcock p38 Mitogen-activated protein kinase-induced glucocorticoid receptor phosphorylation reduces its activity: role in steroid-insensitive asthma J Allergy Clin Immunol 109 2002 649 657
33. T.K. Loke, K.H. Mallett, J. Ratoff, B.J. O'Connor, S. Ying, and Q. Meng Systemic glucocorticoid reduces bronchial mucosal activation of activator protein 1 components in glucocorticoid-sensitive but not glucocorticoid-resistant asthmatic patients J Allergy Clin Immunol 118 2006 368 375
34. M. Hernandez, W.J. Brickey, N.E. Alexis, R.C. Fry, J.E. Rager, and B. Zhou Airway cells from atopic asthmatic patients exposed to ozone display an enhanced innate immune gene profile J Allergy Clin Immunol 129 2012 259 261
35. J.A. Nightingale, D.F. Rogers, L.A. Hart, S.A. Kharitonov, K.F. Chung, and P.J. Barnes Effect of inhaled endotoxin on induced sputum in normal, atopic, and atopic asthmatic subjects Thorax 53 1998 563 571
36. H. Ghanim, S. Abuaysheh, C.L. Sia, K. Korzeniewski, A. Chaudhuri, and J.M. Fernandez-Real Increase in plasma endotoxin concentrations and the expression of Toll-like receptors and suppressor of cytokine signaling-3 in mononuclear cells after a high-fat, high-carbohydrate meal Diabetes Care 32 2009 2281 2287
37. S. Pendyala, J.M. Walker, and P.R. Holt A high-fat diet is associated with endotoxemia that originates from the gut Gastroenterology 142 2012 1100 1101
38. P.D. Cani, J. Amar, M.A. Iglesias, M. Poggi, C. Knauf, and D. Bastelica Metabolic endotoxemia initiates obesity and insulin resistance Diabetes 56 2007 1761 1772
39. P.D. Cani, R. Bibiloni, C. Knauf, Waget Al, A.M. Neyrinck, and N.M. Delzenne Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice Diabetes 57 2008 1470 1481
40. S. Kennedy, R. Elwood, B. Wiggs, P. Pare, and J. Hogg Increased airway mucosal permeability of smokers: relationship to airway reactivity Am Rev Respir Dis 129 1984 143 148
41. A.P.B. Moreira, T.F.S. Texeira, A.B. Ferreira, M. do Carmo Gouveia Peluzio, and R. de Cássia Gonçalves Influence of a high-fat diet on gut microbiota, intestinal permeability and metabolic endotoxaemia Br J Nutr 108 2012 801 809
42. L.G. Wood, M.L. Garg, and P.G. Gibson A high-fat challenge increases airway inflammation and impairs bronchodilator recovery in asthma J Allergy Clin Immunol 127 2011 1133 1140
43. R.M. Castellan, S.A. Olenchock, K.B. Kinsley, and J.L. Hankinson Inhaled endotoxin and decreased spirometric values N Engl J Med 317 1987 605 610
44. O. Michel, J. Duchateau, and R. Sergysels Effect of inhaled endotoxin on bronchial reactivity in asthmatic and normal subjects J Appl Physiol 66 1989 1059 1064
45. J. Kline, J.D. Cowden, G. Hunninghake, B. Schutte, J. Watt, and C. Wohlford-Lenane Variable airway responsiveness to inhaled lipopolysaccharide Am J Respir Crit Care Med 160 1999 297 303